BonaTech Showcases at Premier Biopharma Events in Suzhou & Qingdao
Recently, BonaTech was invited to participate in two concurrent events—the "2025 Suzhou ADC & Novel Antibody Drug Process & Quality Control Summit" and the "2025 Qingdao Specialized Workshop on Biomanufacturing Pilot Platform Development, Operation Management & Key Fermentation Scale-up Technologies." Through this two-pronged presence, BonaTech leveraged its comprehensive membrane technology portfolio and system solutions to empower the full biopharmaceutical value chain—from upstream fermentation pilot scale-up to downstream antibody drug purification and quality control.
Suzhou · ADC & Novel Antibody Drug Process & Quality Control Summit
Downstream · Antibody Drug Purification & Quality Control
Focused on process development and quality control for ADCs and novel antibody drugs, the summit addressed the refined needs of downstream purification—where BonaTech showcased its membrane separation solutions for antibody drug purification and QC.
Qingdao · Biomanufacturing Pilot Platform Workshop
Upstream · Fermentation Pilot Scale-up (Nov 20–22)
Centered on biomanufacturing pilot platform development and operation management, as well as key fermentation scale-up technologies, BonaTech shared practical experience and systematic solutions for membrane filtration systems in pilot process scale-up.
Dual-City Presence Showcases Full Value-Chain Solution Capability
BonaTech's synchronized appearance in Suzhou and Qingdao was designed to precisely meet the needs of customers across different biopharmaceutical segments, demonstrating its integrated technical strength spanning both upstream and downstream. At the events, BonaTech's booth drew a steady stream of attendees for in-depth discussions. The technical team engaged clients in deep dialogue on the application of membrane materials, modules, and systems in scenarios such as antibody drug purification and fermentation broth clarification and concentration.
▲ BonaTech at the 2025 Suzhou ADC & Novel Antibody Drug Process & Quality Control Summit
▲ BonaTech at the 2025 Qingdao Specialized Workshop on Biomanufacturing Pilot Platform Development, Operation Management & Key Fermentation Scale-up Technologies
The rapid growth of the biopharmaceutical industry places higher and more refined demands on separation and purification technologies. Building on this dual-city engagement, BonaTech looks forward to deepening exchanges with peers worldwide, advancing the industry together through proven technical expertise, and safeguarding the R&D and production of global customers with reliable technologies and equipment.
Relentless Commitment, Building Benchmark Strength in the Industry
Since its founding in 2012, BonaTech has been dedicated to material extraction, separation, and purification. Recognized as a National High-Tech Enterprise and a provincial-level "Specialized, Refined, Differentiated & Innovative" (专精特新) enterprise, the company is a proven leader in the industry. With membrane technology at its core, BonaTech's business spans membrane material R&D, membrane equipment manufacturing, and membrane technology application. Relying on high-performance membrane equipment and cost-effective membrane consumables, it delivers customized, energy-efficient, and eco-friendly integrated membrane separation solutions to global customers.
Today, BonaTech has built a complete industrial chain spanning "Membrane Element – Membrane Module – Membrane Equipment – Membrane Application," effectively breaking the long-standing monopoly of foreign products in the high-end membrane sector. This has driven the deep integration and cross-industry expansion of membrane technology across multiple sectors, and continues to inject momentum into the optimization, upgrading, and sustainable development of China's membrane industry.
▲ On-site, the BonaTech team held in-depth exchanges with attendees
BonaTech warmly invites industry peers to connect and explore the new future of membrane separation technology together!